#shots less effective against Omicron

Drugmaker Moderna (MRNA.O) set off fresh alarm bells in financial markets on Tuesday as the firm's chief warned that COVID-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version.